Increasing evidence suggests that type 2 diabetes mellitus (T2DM) is strongly correlated with Alzheimer's disease (AD). To examine the relationship between T2DM and AD, autoantibodies against amyloid-Abeta were measured in the serum of T2DM patients and age-matched controls. Levels of Abeta autoantibody were measured by ELISA in serum samples of T2DM patients (n=92) and age-matched control group (n=106). Abeta autoantibody levels were increased in T2DM compared with age-matched controls by 45.4 +/- 8.1% (p< 0.001). Females had higher Abeta autoantibody levels than males in both T2DM and control group. Abeta autoantibody levels in the T2DM group were positively correlated with the levels of cholesterol (p=0.011), low density lipoprotein cholesterol (p=0.020), and triglycerides (p=0.039). In conclusion, the level of Abeta autoantibody is dramatically elevated in patient serum of T2DM, and, as such, might be used as a possible biomarker for T2DM.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3233/JAD-2010-1332 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Autoantibody profiles in Alzheimer´s, Parkinson´s, and dementia with Lewy bodies: altered IgG affinity and IgG/IgM/IgA responses to alpha-synuclein, amyloid-beta, and tau in disease-specific pathological patterns.
J Neuroinflammation
December 2024
Centre for Neuroscience and Stereology, Department of Neurology, Bispebjerg and Frederiksberg Hospital, Copenhagen University Hospital, Nielsine Nielsens Vej 6B, Entrance 11B, 2. floor, Copenhagen, NV, DK-2400, Denmark.
Article Synopsis
- Alzheimer's (AD) and Parkinson’s disease (PD) are major neurodegenerative disorders characterized by specific protein aggregations, with Alzheimer’s linked to amyloid-beta (Aβ) and tau, and Parkinson’s associated with alpha-synuclein (αSyn).
- The research examined naturally occurring autoantibodies (nAbs), including IgG, IgM, and IgA, in patients with AD, PD, and dementia with Lewy bodies (DLB), revealing altered levels and affinities of these antibodies compared to healthy controls.
- Findings indicated that AD patients had lower high-affinity anti-αSyn and anti-Aβ IgGs, while DLB patients showed increased anti-αSyn IgG but decreased Ig
Time to reframe the disease staging system for type 1 diabetes.
Lancet Diabetes Endocrinol
December 2024
Department of Paediatrics, Diabetes Center, University of California San Francisco, San Francisco, California, USA.
Article Synopsis
- A disease staging system introduced in 2015 helps identify and track progression to clinical type 1 diabetes based on islet autoantibodies and dysglycaemia, but it has significant limitations such as combining diverse individuals and lacking high specificity.
- Although the current model suggests a linear progression through stages, real-life progression is often more complex, and factors like age are not considered.
- With the recent FDA approval of teplizumab to delay type 1 diabetes at stage 2, there's a need to refine diabetes staging definitions and develop a risk calculator that considers a wider range of demographic, genetic, and metabolic data, especially in underrepresented groups.
Autoantibodies to BACE1 promote Aβ accumulation and neurodegeneration in Alzheimer's disease.
Acta Neuropathol
October 2024
Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing, China.
The profile of autoantibodies is dysregulated in patients with Alzheimer's disease (AD). Autoantibodies to beta-site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1) are present in human blood. This study aims to investigate the clinical relevance and pathophysiological roles of autoantibodies to BACE1 in AD.
View Article and Find Full Text PDFSimultaneous Pancreas-Kidney Transplant Outcomes Stratified by Autoantibodies Status and Pretransplant Fasting C-peptide.
Transplant Direct
November 2024
Division of Transplantation, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI.
Backgrounds: Pancreatic beta cell function and islet autoantibodies classically distinguish types of diabetes (type 1 diabetes mellitus [DM] or type 2 DM). Here, we sought to evaluate simultaneous pancreas-kidney (SPK) transplant outcomes stratified by the presence or absence of beta cell function and autoantibodies.
Methods: SPK recipients were eligible if pretransplant autoantibodies were measured against insulin, islet cell, or glutamic acid decarboxylase 65-kD isoform.
Maternal Thyroid Function and Biochemical Markers of Placental Function in Early Pregnancy.
Clin Endocrinol (Oxf)
October 2024
Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.
Objective: A link between maternal thyroid function and the placental biomarkers, soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF), has been brought forward. This study aimed to describe their association in early pregnancy.
Design: Retrospective cohort study.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!